Works matching IS 11753277 AND DT 2006 AND VI 6 AND IP 5
Results: 10
The Effect of Moxonidine on Endothelial Dysfunction in Metabolic Syndrome.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 343, doi. 10.2165/00129784-200606050-00007
- By:
- Publication type:
- Article
Spotlight on Ranolazine in Chronic Stable Angina Pectoris1.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 357, doi. 10.2165/00129784-200606050-00009
- By:
- Publication type:
- Article
Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 349, doi. 10.2165/00129784-200606050-00008
- By:
- Publication type:
- Article
Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study): Rationale and Baseline Characteristics.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 335, doi. 10.2165/00129784-200606050-00006
- By:
- Publication type:
- Article
Medical Treatment of Patients with Heart Failure or Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 313, doi. 10.2165/00129784-200606050-00004
- By:
- Publication type:
- Article
Therapeutic Potential of Thymosin-β4 and its Derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in Cardiac Healing After Infarction.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 305, doi. 10.2165/00129784-200606050-00003
- By:
- Publication type:
- Article
Optimizing the Pharmacologic Treatment of Hypertension: BP Control and Target Organ Protection.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 287, doi. 10.2165/00129784-200606050-00001
- By:
- Publication type:
- Article
The ASCOT Trial: Clarifying the Role of ACE Inhibition in the Reduction of Cardiovascular Events in Patients with Hypertension.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 327, doi. 10.2165/00129784-200606050-00005
- By:
- Publication type:
- Article
Thiazolidinediones in Patients with Diabetes Mellitus and Heart Failure: Implications of Emerging Data.
- Published in:
- American Journal of Cardiovascular Drugs, 2006, v. 6, n. 5, p. 297, doi. 10.2165/00129784-200606050-00002
- By:
- Publication type:
- Article